Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study

Xiao-Fang Tang, Qin-Xue Li, Ya-Ling Han, Xiao-Zeng Wang, Ying Song, Zheng Zhang, Jing-Jing Xu, Zhen-Yu Liu, Yan Chen, Yong-Zhen Zhang, Pei Zhu, Xiao-Gang Guo, Lin Jiang, Zhi-Fang Wang, Ru Liu, Qing-Sheng Wang, Yi Yao, Ying-Qing Feng, Xue-Yan Zhao, Jin-Qing Yuan

Open source

DOI: 10.1016/j.heliyon.2024.e39748
Published: 2024-11
Container: Heliyon
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.heliyon.2024.e39748,
  title = {Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study},
  author = {Xiao-Fang Tang and Qin-Xue Li and Ya-Ling Han and Xiao-Zeng Wang and Ying Song and Zheng Zhang and Jing-Jing Xu and Zhen-Yu Liu and Yan Chen and Yong-Zhen Zhang and Pei Zhu and Xiao-Gang Guo and Lin Jiang and Zhi-Fang Wang and Ru Liu and Qing-Sheng Wang and Yi Yao and Ying-Qing Feng and Xue-Yan Zhao and Jin-Qing Yuan},
  year = {2024},
  journal = {Heliyon},
  doi = {10.1016/j.heliyon.2024.e39748},
  url = {https://doi.org/10.1016/j.heliyon.2024.e39748}
}

RIS

TY  - JOUR
TI  - Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study
AU  - Xiao-Fang Tang
AU  - Qin-Xue Li
AU  - Ya-Ling Han
AU  - Xiao-Zeng Wang
AU  - Ying Song
AU  - Zheng Zhang
AU  - Jing-Jing Xu
AU  - Zhen-Yu Liu
AU  - Yan Chen
AU  - Yong-Zhen Zhang
AU  - Pei Zhu
AU  - Xiao-Gang Guo
AU  - Lin Jiang
AU  - Zhi-Fang Wang
AU  - Ru Liu
AU  - Qing-Sheng Wang
AU  - Yi Yao
AU  - Ying-Qing Feng
AU  - Xue-Yan Zhao
AU  - Jin-Qing Yuan
PY  - 2024
JO  - Heliyon
DO  - 10.1016/j.heliyon.2024.e39748
UR  - https://doi.org/10.1016/j.heliyon.2024.e39748
ER  -

APA

Tang, X., Li, Q., Han, Y., Wang, X., Song, Y., Zhang, Z., Xu, J., Liu, Z., Chen, Y., Zhang, Y., Zhu, P., Guo, X., Jiang, L., Wang, Z., Liu, R., Wang, Q., Yao, Y., Feng, Y., Zhao, X., & Yuan, J. (2024). Implications of baseline glycemic control by plasma glycated hemoglobin A1c on adverse outcomes in patients with coronary heart disease and type 2 diabetes mellitus: Results from the PROMISE study. Heliyon. https://doi.org/10.1016/j.heliyon.2024.e39748

Source records

crossref · retrieved 2026-09-26T23:00:53.199Z